Aisling Capital — 2014 Investments
4 investments dated 2014 · listed companies and verified rows first · show all
HealthtechOrlando, US
Randy W Frey(Director)Alan B Connaughton(Executive Officer)Amy R Brooks(Executive Officer)Peter J Mariani(Executive Officer)Keith H Edwards(Executive Officer)Ronald D Goldrich(Executive Officer)
Board seatSteven ElmsJosh Bilenker· per SEC Form D
Co-investorsVersant Venture AIV Holdings
Advion Interchim Scientific develops mass spectrometry instruments, including compact chemist-centric mass spectrometers, nanoelectrospray ionization sources, and ICP-MS systems for elemental analysis.
BiotechDeep TechHardwareIthaca, US
Jamey Jones(Chief Executive Officer)John G. Freund(Director)John D. Henion(Director)J. Kenneth Walker(Director)Zachary Shulman(Director)Francis H. Zenie(Director)
Co-investorsGefinor Capital
Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.
BiotechHealthtechMedical DevicesDenmark, DK
Jan Møller Mikkelsen(Founder, President and Chief Executive Officer)James Healy(Director)Grethe Rasmussen(Executive Officer)Harald Rau(Executive Officer)Rafa?le Tordjman(Director)Martin Olin(Director)
Co-investorsVivo CapitalAvoro Capital AdvisorsForesite CapitalRA CapitalSofinnova Ventures
BiotechAnn Arbor, US
Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Roger S. Newton(Director)
Co-investorsAlta PartnersArboretum VenturesARCHIMED JapanAsset Management CompanyCanaan PartnersLongitude Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.